首页 | 本学科首页   官方微博 | 高级检索  
检索        

硫普罗宁在乳癌化疗中的保肝作用
引用本文:张勇,邹天宁,聂建云.硫普罗宁在乳癌化疗中的保肝作用[J].现代医药卫生,2002,18(7):561-561.
作者姓名:张勇  邹天宁  聂建云
作者单位:云南省肿瘤医院,650118
摘    要:目的:观察硫普罗宁(凯西莱)在乳癌化疗轻度肝损害患者中的保肝作用。方法:对56例乳癌选用CMF方案,患者随机分为治疗组和对照组。治疗组28例加凯西莱静滴及口服,28例患者为对照组用肌苷静滴及口服,观察一周期化疗后ALT的变化,结果治疗组化疗后ALT值显著低于化疗前组,与对照组比较差异有显著性。结论:对乳癌化疗轻度肝损伤患者凯西莱可对抗化疗性肝损害,改善肝脏功能,保证化疗连续性。

关 键 词:硫普罗宁  乳癌  化疗  肝损害  临床分析
文章编号:1009-5519(2002)07-0561-01

Protective hepatic role of tiopronin in the patients with breast cancer during chemotherapy.
Zhang Yong,Zou Tianning,Nie Jianyun.Yunnan Tumor Hospital,Kunming ..Protective hepatic role of tiopronin in the patients with breast cancer during chemotherapy.[J].Modern Medicine Health,2002,18(7):561-561.
Authors:Zhang Yong  Zou Tianning  Nie JianyunYunnan Tumor Hospital  Kunming
Institution:Zhang Yong,Zou Tianning,Nie Jianyun.Yunnan Tumor Hospital,Kunming 650118.
Abstract:Objective:To observe the protective hepatic role of tiopronin in the patient's of breast cancer with mild hepatic injury during chemotherapy.Methods:In the therapeutic group the chemotherapy and tiopronin were used.the chemotherapy and ATP were used in the control group.The change of ALT was observed for a week after chemotherapy.Results:The level of ALT in the therapeutic group after chemotherapy was obviously lower than that of control group and before chemotherapy(P<0 01).Conclusion:Tiopronin has counteraction chemotherapy on hepatic injury in the patient's of breast cancer with mild hepatic injury during chemotherapy.it may improve hepatic function and ensure the continuity of chemotherapy.
Keywords:Tiopronin Breast cancer Chemotherapy Hepatic injury
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号